Back to User profile » Prof. Dr. Kazuyuki Kobayashi
Papers published by Prof. Dr. Kazuyuki Kobayashi:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates
Suraya R, Tachihara M, Nagano T, Nishimura Y, Kobayashi K
Cancer Management and Research 2022, 14:2079-2090
Published Date: 22 June 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Caspase Recruitment Domain-Containing Protein 9 Expression is a Novel Prognostic Factor for Lung Adenocarcinoma
Miwa N, Nagano T, Jimbo N, Dokuni R, Kiriu T, Mimura C, Yasuda Y, Katsurada M, Yamamoto M, Tachihara M, Tanaka Y, Kobayashi K, Itoh T, Maniwa Y, Nishimura Y
OncoTargets and Therapy 2020, 13:9005-9013
Published Date: 10 September 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
Katsurada N, Tachihara M, Hatakeyama Y, Koyama K, Yumura M, Kiriu T, Dokuni R, Hazama D, Tokunaga S, Tamura D, Nakata K, Yamamoto M, Kamiryo H, Kobayashi K, Tanaka Y, Maniwa Y, Nishimura Y
Cancer Management and Research 2020, 12:777-782
Published Date: 3 February 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study
Kiriu T, Yamamoto M, Nagano T, Hazama D, Sekiya R, Katsurada M, Katsurada N, Tachihara M, Kobayashi K, Nishimura Y
OncoTargets and Therapy 2019, 12:10559-10568
Published Date: 2 December 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review
![](cr_data/cache/submission_images/s225000/225832/01_nov_2019_225832_fig1_200_200_90.jpg)
Yasuda Y, Nagano T, Tachihara M, Chihara N, Umezawa K, Katsurada N, Yamamoto M, Sekiguchi K, Kobayashi K, Nishimura Y
Therapeutics and Clinical Risk Management 2019, 15:1283-1289
Published Date: 1 November 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
Tachihara M, Kiriu T, Hata A, Hatakeyama Y, Nakata K, Nagano T, Yamamoto M, Kobayashi K, Ohnishi H, Katakami N, Nishimura Y
Cancer Management and Research 2019, 11:7135-7140
Published Date: 29 July 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
Effendi WI, Nagano T, Tachihara M, Umezawa K, Kiriu T, Dokuni R, Katsurada M, Yamamoto M, Kobayashi K, Nishimura Y
Cancer Management and Research 2019, 11:3669-3679
Published Date: 29 April 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Lung squamous cell carcinoma associated with hypoparathyroidism with sensorineural deafness and renal dysplasia syndrome: a case report
![](cr_data/cache/submission_images/s161000/161420/20_mar_2018_161420_fig5_200_200_90.jpg)
Kojima M, Nagano T, Nakata K, Hara S, Katsurada N, Yamamoto M, Tachihara M, Kamiryo H, Kobayashi K, Usui T, Nishimura Y
OncoTargets and Therapy 2018, 11:1595-1599
Published Date: 20 March 2018